Jennifer Gumer
Lecturer | Loyola Marymount University
Lost Angeles, CA, UNITED STATES
Jennifer Gumer is an expert at the intersection of policy and science and biotechnology.
Media
Publications:
Documents:
Videos:
Audio/Podcasts:
Biography
Jennifer M. Gumer always knew she wanted to study science—she just didn’t want to be a scientist. While studying biology, with a focus on genetics, at the University of California San Diego, she learned that she didn’t like lab work. Her interest in exploring the social effects of science led her to law school and later to the firm Gibson, Dunn & Crutcher LLP, where she represented clients in the pharmaceutical, medical device, and health insurance industries.
Education (3)
Columbia University: M.A., Bioethics/Medical Ethics 2017
New York University School of Law: J.D. 2011
University of California - San Diego: B.Sc., Biology & Creative Writing 2007
Areas of Expertise (4)
Bioethics
Legal Research
Litigation
Securities Regulation
Industry Expertise (3)
Judiciary
Education/Learning
Legal Services
Media Appearances (1)
Jennifer M. Gumer: Discovering Bioethics at the Intersection of Science and the Law
Columbia University - School of Professional Studies online
Jennifer M. Gumer always knew she wanted to study science—she just didn’t want to be a scientist. While studying biology, with a focus on genetics, at the University of California San Diego, she learned "pretty quickly" that she didn’t like lab work, she said. “And I faint whenever I get my blood taken, so I wasn’t going to be a doctor."
Articles (2)
The Wisdom of Germline Editing: An Ethical Analysis of the Use of CRISPR-Cas9 to Edit Human Embryos
The New Bioethics2019 With recent reports that a Chinese scientist used CRISPR-Cas9 to heritably edit the genomes of human embryos brought to term, discussions regarding the ethics of the technology are urgently needed. Although certain applications of germline editing have been endorsed by both the National Academy of Sciences and the Nuffield Council, this paper explores the ethical concerns related even to such therapeutic uses of the technology.
Why Human Germline Editing Might Never Be Legal in the U.S.
Albany Medical College - Bioethics Online2019-08-09
A Russian scientist recently announced his intention to use the gene-editing tool CRISPR to edit and implant human embryos—a revelation that met with international outcry similar to the condemnation of the Chinese scientist He Jiankui last year when he announced that he had created the first gene-edited babies.
Social